Wednesday, April 30, 2025

Life Sciences

Microsoft
Microsoft Corp. is expanding its collaboration with NVIDIA to bring the power of generative AI, the cloud and accelerated computing to healthcare and life sciences organizations. The collaboration will bring together the global scale, security and advanced computing capabilities of Microsoft Azure with NVIDIA DGX Cloud and the NVIDIA Clara suite of computing platforms, software...
Lantern Pharma
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, announced the dosing of the first two patients in the Phase 1 clinical trial evaluating Lantern’s investigational new drug...
Bayer
Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, and a global leader in using computational pathology to transform complex biomedical data...
Deepcell
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced the launch of its Beta Program for the REM-I platform. Sites testing the REM-I platform are a selected number of leading academic institutions and medical centers in the U.S. and Europe including Newcastle...
Rapid Novor
Rapid Novor and MAbSilico partner to provide the world's first comprehensive AI-guided epitope mapping service. This service combines hydrogen-deuterium exchange mass spectrometry (HDX-MS) with advanced artificial intelligence (AI)-driven computational modeling. The result is a powerful platform capable of accurately predicting and validating binding epitopes for monoclonal antibodies. This approach...
Zephyr AI
Latest Investment Will Support the Democratization of Precision Medicine Through the Advancement of Novel Explainable AI Algorithms Zephyr AI, Inc., a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, announced it has successfully closed a $111 million Series A funding round...
Google Cloud
Updates to Vertex AI Search, Healthcare Data Engine, and MedLM bring Google innovations to Cloud customers and ultimately improve patient care Google Cloud announced several new solutions to help healthcare and life sciences organizations enable interoperability, build a better data foundation for their businesses, and deploy generative AI (gen AI)...
Klick
KCM+AI provides pharma brands with enhanced handling of pharmacovigilance issues via 24/7 monitoring and automatic comment-holding Klick Health launched Klick Comment Moderator+AI (KCM+AI), the life sciences industry’s first social media comment moderator powered by artificial intelligence. KCM+AI is powered by Microsoft Azure AI and a proprietary Klick model trained on almost...
Ordaōs
 Carterra technology will allow Ordaōs to accelerate its mission of leveraging advanced technologies to efficiently and effectively design novel life-changing therapies for patients in need. Ordaōs, a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, announced it has acquired an LSA platform from Carterra, a leading provider...
The Jackson Laboratory
Two world-leading organizations are partnering to further expand AI capabilities in biomedical science and catalyze medical progress. What can happen when prominent institutions in technology and research form a partnership to accelerate the implementation of artificial intelligence (AI) to enhance biomedical research and clinical care? A recent agreement in the...